Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience.

@article{Freyer2004UnexpectedTI,
  title={Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience.},
  author={Gilles Freyer and Alain H. Lortholary and Corinne Delcambre and Thierry Delozier and Gilles Piot and Françoise Genin and {\'E}ric Pujade-Lauraine},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2004},
  volume={16 1},
  pages={
          17-23
        }
}
AIMS Chemotherapy can be considered for many elderly patients with metastatic hormone-resistant breast cancer. Idarubicin, the only orally administrated cytotoxic agent belonging to the anthracycline family, may be a potential alternative to intravenous chemotherapy for this population for quality-of-life reasons. MATERIALS AND METHODS Between November 2000 and June 2001, 26 consecutive patients were included in an open, multicentre, phase II trial. All patients presented with metastatic… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Similar Papers

Loading similar papers…